Your browser doesn't support javascript.
loading
Clinical Manifestation of Ralstonia mannitolilytica Infection in Pediatric Patients and Epidemiological Investigation of Outbreaks.
Kim, Gahee; Yoo, Ree Nar; So, Hyejin; Lee, Jeong-Young; Kim, Mi-Na; Kim, Sung-Han; Jhang, Won Kyoung; Park, Seong Jong; Lee, Jina.
Afiliação
  • Kim G; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Yoo RN; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • So H; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee JY; Office for Infection Control, Asan Medical Center, Seoul, Korea.
  • Kim MN; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim SH; Office for Infection Control, Asan Medical Center, Seoul, Korea.
  • Jhang WK; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park SJ; Office for Infection Control, Asan Medical Center, Seoul, Korea.
  • Lee J; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Korean Med Sci ; 38(33): e252, 2023 Aug 21.
Article em En | MEDLINE | ID: mdl-37605494
ABSTRACT

BACKGROUND:

Ralstonia mannitolilytica is a causative organism of nosocomial infections, particularly associated with contaminated water, and resistant to various antibiotics, including carbapenems. Several clusters of R. mannitolilytica infections appeared in children at our institute from August 2018 to November 2019.

METHODS:

From March 2009 to March 2023, all patients admitted to Asan Medical Center Children's Hospital in Seoul, Korea, with culture-confirmed R. mannitolilytica and corresponding clinical signs of infection were identified. Epidemiological and environmental investigations were conducted. Polymerase chain reaction (PCR) was performed for the genes of OXA-443 and OXA-444 on R. mannitolilytica isolates.

RESULTS:

A total of 18 patients with R. mannitolilytica infection were included in this study, with 94.4% (17/18) and 5.6% (1/18) being diagnosed with pneumonia and central line-associated bloodstream infection, respectively. All-cause 30-day mortality rate was 61.1% (11/18), and seven of the fatal cases were caused by R. mannitolilytica infection itself. The resistance rates to meropenem and imipenem werew 94.4% (17/18) and 5.6% (1/18), respectively. Although four out of nine meropenem-resistant R. mannitolilytica isolates had positive PCR results for OXA-443 and OXA-444 genes, there were no significant differences in antimicrobial susceptibility patterns. Environmental sampling identified R. mannitolylica at two sites a cold-water tap of a water purifier and an exhalation circuit of a patient mechanical ventilator. After implementing and improving adherence to infection control policies, no additional R. mannitolilytica infection cases have been reported since December 2019.

CONCLUSION:

R. mannitolilytica can cause life-threatening infections with high mortality in fragile pediatric populations. To prevent outbreaks, healthcare workers should be aware of R. mannitolilytica infections and strive to comply with infection control policies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Surtos de Doenças / Antibacterianos Limite: Child / Humans Idioma: En Revista: J Korean Med Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Surtos de Doenças / Antibacterianos Limite: Child / Humans Idioma: En Revista: J Korean Med Sci Ano de publicação: 2023 Tipo de documento: Article